Follow Us
  • Facebook Basic Black
  • Twitter Basic Black
  • LinkedIn Social Icon

"Breakthrough powdered insulin inhaler offers diabetes patients alternative to injections"

"Sam Finta has always been fit and considered himself healthy. Everything changed with a diagnosis of Type 1 diabetes in 1999."

It's a lifelong disease and you have to manage it several hours a day," Finta said.

But that all changed when he became part of a clinical trial for a powdered form of insulin called Afrezza.

Rather than pumps and injections, the drug comes in a little whistle-like device that is inhaled just before mealtime."

Click here to read the full article


#type1 #news #America

Must Read

Awards & Honors

All Contents © Copyright Epinex Diagnostics, Inc. 2011. All Rights Reserved